Day 1 | 3rd November

Accelerating Evidence-based Action for Every Family Everywhere LAUNCH: WHO’s Full Value of Vaccines Assessment Report

Wednesday 3rd November from 1.30 pm (free to attend virtually online), Time Zone London, UK (GMT)

Hosted by The London School of Hygiene & Tropical Medicine

Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date, most focus has been on infections in children, yet there are many additional consequences for women themselves, including stillbirths, preterm birth and long-term impacts for affected survivors. The WHO-led Value Case Proposition includes years of work by many teams from all over the world on new data, analysis regarding long-term health and economic consequences of GBS disease, and estimated costs/benefits of vaccination or other prevention approaches. The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this Report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030.

This event will be live-streamed here: https://www.who.int/news-room/events/detail/2021/11/03/default-calendar/issad-global-conference-on-group-b-strep

You can also join the webinar here: https://lshtm.zoom.us/j/96388532300

There is no password to join the link above on Wednesday 3rd November at 13.30 pm (GMT). (You will not be able to join the webinar link before the 3rd of November).

Full agenda below.